Welcome

This forum is for IRIS Industry users' discussion and self-help. You need to login to the portal with an IRIS account to post a new thread or reply to an existing one.
EMA staff monitors the forum and may intervene in conversation, however a reply cannot be guaranteed. This Forum does not replace the existing communication channels:
  • Questions on ongoing procedures at EMA should be submitted as a reply to any email received from IRIS regarding the specific case.
  • Use this form to send a request for information from the European Medicines Agency or to make a formal request for access to EMA documents that are not already published on the EMA website
  • Problems and technical issues about IRIS should be reported to the EMA ServiceNow. If you have difficulties in obtaining a role or affiliation to access IRIS, please select "IRIS account access and management" as the service, in the specific ServiceNow page.
Please do not post confidential information in the forum.
Thread Author Last post Replies
Discrepance between online form and auto-generated application form Hilary Gray
Hilary Gray
2
SAWP dates for 2021 ? Isha Arora
Tarita Toufexi
1
Parallel distribution - To cover or not to cover original batch and expiry Mikael Zad
Anna Fiodorova
1
Transfer of ODD from inactive/ dormant entity Sam Bryant
Monica Gomar Mengod
1
Final version scientific document Stéphane Halleux
Paolo Tomasi
1
Marketing Status reporting implementation plan and baseline requirements Roberta Bernardelli
Paolo Tomasi
1
Request protocol assistance for one molecule under multiple ODDs Stephanie Pham
Tarita Toufexi
1
Variations Erik Grimmelihuysen
Paolo Tomasi
1
IRIS Industry Contributor Tanya Konovalenko
Paolo Tomasi
1
Has my SA submission been accepted? Awaiting Validation of Scientific Advice? Gioia Riboni Verri
Paolo Tomasi
1
Status of Submission - Scientific Advice Shilpa Jain
Paolo Tomasi
1
MAA field in the Procedural Information section of the SA IRIS form Ian Hardern
Paolo Tomasi
1
Accidentally withdrawing an RPI request - help with next steps Caroline Langham
Paolo Tomasi
1
Follow up Scientific Advice - Reference to previous Scientific Advice Petra Bettendorf
Paolo Tomasi
3
SA request submission by co-development partner Ian Hardern
Paolo Tomasi
6
Submitting annual report in orphan designation Dorte Dyregaard
Monica Gomar Mengod
3
Non-EU based consultants Luisa Pachés-Samblás
Paolo Tomasi
5
Use of regulatory consultants Luisa Pachés-Samblás
Luisa Pachés-Samblás
2
Technical specification Susanne Hense
Paolo Tomasi
5
Marketing Status Reporting Susanne Hense
Susanne Hense
2

You must be signed in to post in this forum.